2.69
price up icon0.00%   0.00
after-market Handel nachbörslich: 2.68 -0.010 -0.37%
loading

Savara Inc Aktie (SVRA) Neueste Nachrichten

pulisher
Feb 18, 2025

Savara Inc. Awards Stock Options and RSUs to New Employees - MSN

Feb 18, 2025
pulisher
Feb 14, 2025

SVRASavara Inc Latest Stock News & Market Updates - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

Savara Announces New Employment Inducement Grant - Milton Daily Standard

Feb 14, 2025
pulisher
Feb 14, 2025

Savara's Latest Executive Compensation Package Revealed: Key Details on New Employee Stock Awards - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

A company insider recently sold 25,000 shares of Savara Inc [SVRA]. Should You Sale? - Knox Daily

Feb 14, 2025
pulisher
Feb 10, 2025

SG Americas Securities LLC Has $158,000 Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Feb 10, 2025
pulisher
Feb 10, 2025

SVRA’s latest rating updates from top analysts. - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Positive Signs As Multiple Insiders Buy Savara Stock - Yahoo Finance UK

Feb 08, 2025
pulisher
Feb 04, 2025

Investing in Savara Inc (SVRA) Is Getting More Attractive - Knox Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Savara Inc. to Present at Upcoming Healthcare Investor Conferences - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Savara Inc. Publishes Promising Long-Term Outcomes for aPAP Treatment - MSN

Feb 03, 2025
pulisher
Jan 31, 2025

Analysts Predict How High Savara Inc (SVRA) Will Go. - Stocks Register

Jan 31, 2025
pulisher
Jan 31, 2025

JPMorgan Chase & Co. Purchases 13,420 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Molgramostim shows promise in rare lung disease treatment - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

SVRA stock touches 52-week low at $2.6 amid market challenges - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research - Business Wire

Jan 30, 2025
pulisher
Jan 29, 2025

Savara Announces Participation in Upcoming Healthcare Investor Conferences - The Bakersfield Californian

Jan 29, 2025
pulisher
Jan 29, 2025

Savara Inc (NASDAQ:SVRA) Receives $9.86 Average PT from Brokerages - Defense World

Jan 29, 2025
pulisher
Jan 26, 2025

Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 26, 2025
pulisher
Jan 26, 2025

Title: Savara Inc. Approves 2025 Executive Officers’ Target Bonus Amounts - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Savara sets executive bonus targets for 2025 - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Savara sets executive bonus targets for 2025 By Investing.com - Investing.com Australia

Jan 23, 2025
pulisher
Jan 23, 2025

Savara Sets 2025 Executive Bonus Targets - TipRanks

Jan 23, 2025
pulisher
Jan 18, 2025

Savara Inc Updates Corporate Presentation in Latest SEC Filing - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

Savara (NASDAQ:SVRA) Stock Price Down 5.3%Here's What Happened - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment - MSN

Jan 16, 2025
pulisher
Jan 15, 2025

Savara Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Savara (NASDAQ:SVRA) Shares Up 8.1%Should You Buy? - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Barclays PLC Buys 158,244 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Savara Highlights MOLBREEVI’s Potential in Rare Disease Market - TipRanks

Jan 13, 2025
pulisher
Jan 11, 2025

Institutional investors may adopt severe steps after Savara Inc.'s (NASDAQ:SVRA) latest 11% drop adds to a year losses - Simply Wall St

Jan 11, 2025
pulisher
Jan 11, 2025

Savara Inc (NASDAQ:SVRA) Shares Sold by Jane Street Group LLC - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

SVRA Stock Touches 52-Week Low at $2.81 Amid Market Challenges By Investing.com - Investing.com South Africa

Jan 11, 2025
pulisher
Jan 10, 2025

SVRA Stock Touches 52-Week Low at $2.81 Amid Market Challenges - Investing.com Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Savara Inc. Grants Inducement Awards to New Employees - MSN

Jan 09, 2025
pulisher
Jan 08, 2025

Principal Financial Group Inc. Sells 7,607 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Jan 08, 2025
pulisher
Jan 04, 2025

Savara Inc (NASDAQ:SVRA) Receives $9.86 Average Price Target from Brokerages - Defense World

Jan 04, 2025
pulisher
Jan 01, 2025

Savara Inc (NASDAQ:SVRA) Receives $9.86 Consensus Target Price from Analysts - MarketBeat

Jan 01, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Raises Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Buys 264,825 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Jan 01, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Kapitalisierung:     |  Volumen (24h):